Ke-he Ruan

Holistic Medicine

6723 Weslayan St
Houston, TX 77005

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Latest advancements in the study of the relationship between NSAIDs and three prostaglandin E2 synthases.

Latest advancements in the study of the relationship between NSAIDs and three prostaglandin E2 synthases.

Journal: Future medicinal chemistry

Published: September 13, 2023

Reprogramming Megakaryocytes for Controlled Release of Platelet-like Particles Carrying a Single-Chain Thromboxane A2 Receptor-G-Protein Complex with Therapeutic Potential.

Reprogramming Megakaryocytes for Controlled Release of Platelet-like Particles Carrying a Single-Chain Thromboxane A2 Receptor-G-Protein Complex with Therapeutic Potential.

Journal: Cells

Published: August 03, 2023

Design, synthesis and characterization of lead compounds as anti-inflammatory drugs targeting mPGES-1 via enzymelink screening.

Design, synthesis and characterization of lead compounds as anti-inflammatory drugs targeting mPGES-1 via enzymelink screening.

Journal: Future medicinal chemistry

Published: May 30, 2023

Latest progress in the development of cyclooxygenase-2 pathway inhibitors targeting microsomal prostaglandin E2 synthase-1.

Latest progress in the development of cyclooxygenase-2 pathway inhibitors targeting microsomal prostaglandin E2 synthase-1.

Journal: Future medicinal chemistry

Published: January 05, 2022

Recent advances of cannabidiol studies in medicinal chemistry, pharmacology and therapeutics.

Recent advances of cannabidiol studies in medicinal chemistry, pharmacology and therapeutics.

Journal: Future medicinal chemistry

Published: September 29, 2021

Engineering 'Enzymelink' for screening lead compounds to inhibit mPGES-1 while maintaining prostacyclin synthase activity.

Engineering 'Enzymelink' for screening lead compounds to inhibit mPGES-1 while maintaining prostacyclin synthase activity.

Journal: Future medicinal chemistry

Published: June 03, 2021

Redirecting thromboxane A2 and prostacyclin biosyntheses from thrombotic to antithrombotic property by an Enzymelink.

Redirecting thromboxane A2 and prostacyclin biosyntheses from thrombotic to antithrombotic property by an Enzymelink.

Journal: Future medicinal chemistry

Published: March 24, 2021

The Protective Effects of Up-Regulating Prostacyclin Biosynthesis on Neuron Survival in Hippocampus.

The Protective Effects of Up-Regulating Prostacyclin Biosynthesis on Neuron Survival in Hippocampus.

Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

Published: September 30, 2019

Recent advances and near future of insulin production and therapy.

Recent advances and near future of insulin production and therapy.

Journal: Future medicinal chemistry

Published: August 31, 2019

Acute changes in colonic PGE2 levels as a biomarker of efficacy after treatment of the Pirc (F344/NTac-Apc am1137) rat with celecoxib.

Acute changes in colonic PGE2 levels as a biomarker of efficacy after treatment of the Pirc (F344/NTac-Apc am1137) rat with celecoxib.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: August 20, 2019

A novel single-chain enzyme complex with chain reaction properties rapidly producing thromboxane A2 and exhibiting powerful anti-bleeding functions.

A novel single-chain enzyme complex with chain reaction properties rapidly producing thromboxane A2 and exhibiting powerful anti-bleeding functions.

Journal: Journal of cellular and molecular medicine

Published: April 15, 2019

Advances in extracellular ligand recognition sites on prostanoid receptors.

Advances in extracellular ligand recognition sites on prostanoid receptors.

Journal: Future medicinal chemistry

Published: April 21, 2018

Showing 1-12 of 31

Last Updated: 09/26/2026